1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Exocrine Pancreatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Exocrine Pancreatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Exocrine Pancreatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Exocrine Pancreatic Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Exocrine Pancreatic Insufficiency 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Abbott Laboratories 33
Clinical Trial Overview of Abbott Laboratories 33
Forest Laboratories, Inc. 35
Clinical Trial Overview of Forest Laboratories, Inc. 35
Digestive Care, Inc. 36
Clinical Trial Overview of Digestive Care, Inc. 36
DATAMAP GmbH 37
Clinical Trial Overview of DATAMAP GmbH 37
Parexel International Corporation 38
Clinical Trial Overview of Parexel International Corporation 38
Anthera Pharmaceuticals‚ Inc. 39
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 39
LAL Clinica Pesquisa e Desenvolvimento Ltda 40
Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimento Ltda 40
Johnson and Johnson 41
Clinical Trial Overview of Johnson and Johnson 41
Axcan Pharma Inc. 42
Clinical Trial Overview of Axcan Pharma Inc. 42
AbbVie Inc. 43
Clinical Trial Overview of AbbVie Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44
Clinical Trial Overview of Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44
The Foundation for Liver Research 45
Clinical Trial Overview of The Foundation for Liver Research 45
University of Pennsylvania 46
Clinical Trial Overview of University of Pennsylvania 46
Azienda Ospedaliera Universitaria Integrata Verona 47
Clinical Trial Overview of Azienda Ospedaliera Universitaria Integrata Verona 47
Calvary Mater Newcastle 48
Clinical Trial Overview of Calvary Mater Newcastle 48
Columbia University 49
Clinical Trial Overview of Columbia University 49
Seattle Children's Hospital 50
Clinical Trial Overview of Seattle Children's Hospital 50
Sheffield Teaching Hospitals NHS Foundation Trust 51
Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 51
Texas AandM University 52
Clinical Trial Overview of Texas AandM University 52
The University of Tokyo 53
Clinical Trial Overview of The University of Tokyo 53
Five Key Clinical Profiles 54
Appendix 87
Abbreviations 87
Definitions 87
Research Methodology 88
Secondary Research 88
About GlobalData 89
Contact Us 89
Disclaimer 89
Source 89

List of Tables
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exocrine Pancreatic Insufficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Exocrine Pancreatic Insufficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Exocrine Pancreatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 33
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 35
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Digestive Care, Inc., 2015* 36
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by DATAMAP GmbH, 2015* 37
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Parexel International Corporation, 2015* 38
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2015* 39
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LAL Clinica Pesquisa e Desenvolvimento Ltda, 2015* 40
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 41
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Axcan Pharma Inc., 2015* 42
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo, 2015* 44
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Foundation for Liver Research, 2015* 45
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 46
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Integrata Verona, 2015* 47
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Calvary Mater Newcastle, 2015* 48
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 49
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2015* 50
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2015* 51
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas AandM University, 2015* 52
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 53

List of Figures
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.